Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The notices about government funding and the prior Revision: v3.4.1 have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:20:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Results were posted and key endpoints (PFS, ORR, OS, DOR) and health-related QoL data were added, with RECIST criteria and cross-over details described.
    Difference
    2%
    Check dated 2026-02-04T05:11:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option; updated the label 'Last Update Submitted that Met QC Criteria' with new capitalization and bumped the revision to v3.4.0, while removing the older 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' labels.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' indicating that trial results have been submitted, replacing the previous 'No Results Posted' status.
    Difference
    0.0%
    Check dated 2026-01-21T01:21:35.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:25:34.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The Locations section was updated to include new regional site listings across multiple U.S. states and international regions. Some existing location subsections were removed and the revision tag updated from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T09:09:29.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.